Complex genetic and physiological variations as well as environmental factors that drive
emergence of chromosomal instability, development of unscheduled cell death, skewed …

Idiopathic interstitial pneumonias (IIPs) may have an acute or subacute presentation, or
acute exacerbation may occur in a previously subclinical or unrecognized chronic IIP. Acute …

Context Polymyxin B fiber column is a medical device designed to reduce blood endotoxin
levels in sepsis. Gram-negative–induced abdominal sepsis is likely associated with high …

Objective The prognosis of idiopathic pulmonary fibrosis (IPF) patients with acute
exacerbation (AE) is reported to be extremely poor. Several clinical studies suggest that …

Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) is characterized by severe
worsening dyspnea of unknown etiology and high mortality without effective treatment …

Idiopathic pulmonary fibrosis (IPF) is the most common form of idiopathic interstitial
pneumonia. Idiopathic pulmonary fibrosis is often seen in elderly men who smoke. A …

Severe sepsis results in high morbidity and mortality. Immunomodulation strategies could be
an adjunctive therapy to treat sepsis. Endotoxin is a component of gram‐negative bacteria …

Background Acute exacerbation of idiopathic pulmonary fibrosis (AE-IPF) has an extremely
poor prognosis and there is currently no effective treatment for this condition. Direct …

Idiopathic pulmonary fibrosis (IPF) is a fatal progressive lung disease occurring in adults. In
the last decade, the results of a number of clinical trials based on the updated disease …

Background/Aim: Recent reports suggest that polymyxin B (PMX)-immobilized fiber may
have beneficial effects in idiopathic pulmonary fibrosis (IPF) with acute exacerbation (AE) …